Optibiotix Health PLC (LON:OPTIO) (AIM:OPTI) said its OptiBiotix Ltd wholly owned subsidiary has signed a services agreement with Nutraconnect Pte Ltd for the Asia Pacific (APAC) Region.
Nutraconnect, a nutraceutical business growth acceleration service headquartered in Singapore, will develop and implement the go-to-market strategy for prebiotics ingredients SlimBiome and LeanBiome.
"Nutraconnect is an important extension of our commercial experience and reach in the APAC region,” René Kamminga, CEO of OptiBiotix Ltd, said in a statement. “Nutraconnect brings unique regulatory and commercial experience combined with an extensive distribution and agency network in the various countries in the region.
"This partnership will help expedite the commercialisation of our prebiotic technologies in strategic countries in the region. At the same time, it will allow OptiBiotix to focus primarily on established key accounts and building up our North American presence and sales," he added.
Nutraconnect provides end-to-end solutions for global nutraceutical ingredient manufacturers that are looking to establish a foundation for sustainable growth in the fragmented but growing APAC market.
Optibiotix noted that Nutraconnect possesses a wealth of experience in bringing innovative and science-backed nutraceutical ingredients successfully to the market in the region.
OptiBiotix is a life sciences business developing patented science and human study-based compounds that modulate the microbiome to address a range of health-related issues such as metabolic syndrome and diabetes, systemic low-grade inflammation, obesity, cardiovascular disease, high cholesterol and healthy aging,